أوماسيتاكسين

• Homoharringtonine inhibits the NOTCH/MYC pathway and exhibits antitumor effects in T-cell acute lymphoblastic leukemia.Blood · 2024
• Homoharringtonine in the treatment of acute myeloid leukemia: A review.Medicine · 2024
• Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial.Journal of hematology & oncology · 2023
• Homoharringtonine: updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications.European journal of medical research · 2024
• Homoharringtonine synergizes with venetoclax in early T cell progenitor acute lymphoblastic leukemia: Bench and bed.Med (New York, N.Y.) · 2024

via PubMed

Wikidata facts

Mass

545.262482